$FHTX
Foghorn Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateFoghorn Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is FHTX up today? It is at $4.19 (+0.00%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment FHTX spikes, and full due diligence on FHTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $FHTX 17 times in the last 30 days. Create a free account to track $FHTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on FHTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FHTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystFoghorn Therapeutics Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Gottschalk Adrian Officer | Sold (automatic/other) | -59K 0.10% of company | sold 20% | 241K | n/a | Apr 10, 26 |
Gottschalk Adrian Officer | Acquired (grant/award) | +59K 0.10% of company | added 13% | 512K | n/a | Apr 10, 26 |
Gottschalk Adrian Officer | Sold (automatic/other) | -47K 0.08% of company | n/a | n/a | n/a | Apr 9, 26 |
Gottschalk Adrian Officer | Acquired (grant/award) | +47K 0.08% of company | added 29% | 212K | n/a | Apr 9, 26 |
Gottschalk Adrian Officer | Sold (automatic/other) | -300K 0.5% of company | sold 37% | 512K | n/a | Apr 25, 25 |
Gottschalk Adrian Officer | Acquired (grant/award) | +300K 0.5% of company | added 100% | 512K | n/a | Apr 25, 25 |
Gottschalk Adrian Officer | Sold (automatic/other) | -198K 0.3% of company | sold 28% | 512K | n/a | Apr 9, 25 |
Gottschalk Adrian Officer | Acquired (grant/award) | +198K 0.3% of company | added 63% | 512K | n/a | Apr 9, 25 |
Costa Carlos Officer | Sold (automatic/other) | -857 | n/a | n/a | $9K at $10.17 | Sep 23, 24 |
Costa Carlos Officer | Other | 857 | n/a | 857 | $3K at $3.72 | Sep 23, 24 |
Costa Carlos Officer | Sold (automatic/other) | -36K 0.06% of company | n/a | n/a | $359K at $10.04 | Sep 20, 24 |
Costa Carlos Officer | Other | 36K 0.06% of company | n/a | 36K | $133K at $3.72 | Sep 20, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on FHTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for FHTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
FHTX last traded at $4.19, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Foghorn Therapeutics Inc. Common Stock (FHTX) is next expected to report earnings on Wednesday, November 4, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The FHTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged FHTX 17 times in the last 30 days.
FHTX (Foghorn Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $248M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge FHTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$FHTX discussion
Sign in to ask a question or join the discussion.